Over the weekend, I attended numerous multiple myeloma talks in the basic and translational science sessions. Translational research is a term used to describe converting basic science research to...
From Bench to Bedside and Beyond
read more
Jill Zitzewitz, PhD
Jill Zitzewitz, PhD is an associate professor in academic medicine. She spent her career studying therapeutic development for protein misfolding diseases. Since being diagnosed with multiple myeloma in 2017, Jill has been teaching full–time while providing a patient’s perspective through her experiences with multiple myeloma. Current myeloma therapies have allowed her to continue teaching and to be a mother to four young adults. In 2020, Jill became the leader for the central MA multiple myeloma support group of the IMF. This is the third time that Jill will be attending the ASH Conference as a patient advocate rather than as a scientific researcher. She plans to use her background in science and education to help patients understand the important impact of new and novel therapies for treating multiple myeloma.
Follow Jill on X: @JillZitzewitz
Support Group Website: Central MA Multiple Myeloma Support Group
The Fast Pace of Therapeutic Development
Friday was Satellite Symposia Day before the 65th American Society of Hematology Annual Meeting and Exposition (ASH). This day before the kick-off of the official #ASH23 meeting featured many...
Hope and Joy While Waiting
As I write this blog, I’m sitting in the cancer center, waiting to get my monthly maintenance therapy to keep my myeloma at bay. I’m probably one of the last people at my center who still gets...